About
Circle Medical is a venture-backed Y-Combinator healthcare startup on a mission to bring quality, delightful primary care to everyone on the planet. Built by top-tier physicians, engineers, and designers, our medical practice and underlying technology have pioneered how people find and receive care. Our focus on building directly for our patients and providers to address serious care accessibility issues has enabled us to grow over 3X year-over-year. We’re now using our most recent round of f. Circle Medical was founded by JS Boulanger and Brent LaRue. Headquarters: United States.
- Headquarters
- United States
- Founders
- JS Boulanger and Brent LaRue
- Verified backers
- Not disclosed
- Industry
- Healthcare
Trade on Circle Medical
Circle Medical shares
No active listings yet.
Be the first to post →FAQ
Circle Medical private shares
Practical questions on buying, selling, and pricing Circle Medical stock in the secondary market.
How to buy Circle Medical shares?
Circle Medical is privately held, so there is no public ticker and no exchange order book. Stock typically changes hands when early investors, employees, or funds with existing positions decide to sell, often via a broker or a structured secondary. Transfers are usually subject to the company’s right of first refusal and other restrictions in the stockholders’ agreement. If you are eligible, you can post a buy request on Bubex so holders looking to exit Circle Medical can find you.
What is Circle Medical share price?
There is no official Circle Medical share price. Private names do not print a close. Indicative levels can be inferred from the last priced round, tender offers, and reported secondaries, but those prints are not executable quotes and they often disagree with one another. Cross-check platforms and brokers; the better execution is usually the one you actually get filled at, not the headline mark.
Are Circle Medical shares publicly traded?
No. Circle Medical is not listed on NYSE, Nasdaq, or any other public exchange. Any purchase is an off-exchange transfer of existing private stock (or an interest in a vehicle that holds it), not an IPO subscription.
When is the Circle Medical IPO?
Nobody knows. Circle Medical has not filed to go public, and private companies do not publish an IPO date in advance. Rumours, banker mandates, and “late 20XX” chatter are not a timetable — many names stay private, get acquired, or slip the listing by years. Until a registration statement is actually filed, treat any IPO date as unknown and use the secondary market if you need access before a listing.
Who can buy Circle Medical shares on the secondary market?
Secondary access to Circle Medical is generally limited to accredited investors and other eligible counterparties. Even then, the company or its transfer agent may need to approve the transferee. Bubex introduces buyers and sellers; it is not a broker-dealer and does not execute, custody, or settle the trade.
Can I sell Circle Medical shares?
Existing holders — typically employees after a vesting event, early investors, or funds — may be able to sell, subject to lock-ups, ROFR, and company policy. If you hold Circle Medical stock and want liquidity, you can post a sell offer on Bubex to find qualified buyers rather than waiting for a company-run tender.
How is Circle Medical valued if it is still private?
Private-market value is not a single number. Practitioners look at the last primary round, any 409A, reported tender prices, and implied marks from secondaries. Those inputs can diverge: secondaries often trade at a discount or, less often, a premium to the last round. Bubex surfaces the latest disclosed round and any market indications we can corroborate; treat them as context, not a valuation opinion.
What is the difference between Circle Medical’s last funding round and a secondary trade?
A funding round is a primary issuance: the company sells new shares and the post-money valuation is reset. A secondary trade is a transfer of shares already outstanding between two holders; it does not recapitalise Circle Medical the same way. Secondary price per share can therefore sit well away from the last-round mark, which is why you should not treat the headline valuation as your entry price.
Information and introductions only. Bubex does not provide investment advice, brokerage, execution, custody, or settlement. Secondary transfers remain subject to company consents and applicable securities law.